| |
| |
|
| Insider
Information: |
Wirth Peter |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
373,666 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,491,621 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
373,666 |
|
|
| Total
Value |
$6,491,621 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -39.0%
|
-64.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genzyme Corp |
GENZ |
Exec VP,Legal & Corpor... |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director |
2022-10-14 |
0 |
|
0 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
361,666 |
2022-12-08 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2023-06-01 |
12,000 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(134,915) |
0 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
12,000 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$10,952 |
I/I |
(148) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2005-11-29 |
4 |
S |
$74.11 |
$17,119 |
I/I |
(231) |
0 |
|
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2004-11-24 |
4 |
S |
$56.00 |
$81,928 |
D/D |
(1,463) |
6,805 |
|
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2022-12-08 |
4 |
S |
$35.37 |
$136,245 |
D/D |
(3,852) |
342,763 |
0 |
% |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2022-12-08 |
4 |
S |
$35.33 |
$141,320 |
I/I |
(4,000) |
0 |
0 |
% |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-12-08 |
4/A |
B |
$71.36 |
$285,440 |
I/I |
4,000 |
4,000 |
2.1 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-12-08 |
4 |
B |
$71.36 |
$285,440 |
D/D |
4,000 |
342,852 |
2.39 |
% |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2010-05-25 |
4 |
S |
$45.62 |
$304,057 |
D/D |
(6,665) |
15,191 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
|
– • – |
2023-06-29 |
4 |
A |
$26.45 |
$499,984 |
D/D |
18,903 |
361,666 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2005-05-09 |
4 |
OE |
$13.78 |
$656,038 |
D/D |
47,608 |
53,958 |
|
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2004-01-22 |
4 |
OE |
$14.00 |
$700,000 |
D/D |
50,000 |
57,307 |
|
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2005-05-05 |
4 |
OE |
$15.31 |
$833,017 |
D/D |
54,410 |
60,760 |
|
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,158,840 |
D/D |
(15,660) |
29,250 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2010-05-17 |
4 |
OE |
$26.50 |
$1,277,724 |
D/D |
48,216 |
55,072 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2003-07-23 |
4 |
AS |
$50.01 |
$1,716,343 |
D/D |
(34,320) |
7,761 |
|
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,164,500 |
D/D |
(29,250) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2010-05-17 |
4 |
AS |
$50.51 |
$2,435,390 |
D/D |
(48,216) |
6,856 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2004-01-22 |
4 |
AS |
$56.04 |
$2,802,000 |
D/D |
(50,000) |
7,307 |
|
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2005-05-09 |
4 |
S |
$62.36 |
$2,968,835 |
D/D |
(47,608) |
6,350 |
|
- |
|
| GENZ |
Genzyme Corp |
Executive Vice President |
• – – |
2005-05-05 |
4 |
AS |
$62.02 |
$3,374,508 |
D/D |
(54,410) |
6,350 |
|
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2009-01-16 |
4 |
OE |
$29.44 |
$6,835,379 |
D/D |
232,180 |
238,248 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2009-01-16 |
4 |
AS |
$66.50 |
$15,439,970 |
D/D |
(232,180) |
6,068 |
0 |
- |
|
49 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
